Search results
Replay wins IND clearance for PRAME T cell cancer therapy
Pharmaceutical Technology via Yahoo Finance· 19 hours agoPRAME TCR/IL-15 NK (SY-307) is an engineered T cell receptor natural killer (TCR-NK) cell therapy...
New technique improves T cell-based immunotherapies for solid tumors
Medical Xpress· 14 hours agoScientists from Scripps Research have enhanced an existing immunotherapy by removing the sugar coating surrounding solid tumors—such as in melanoma, breast, and prostate cancer—so T ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 2 days agoReplay and MD Anderson announce FDA clearance of IND application for first-in-class PRAME-targeted T-Cell Receptor Natural Killer ...
FAS signalling pathway is crucial for CAR T cell persistence - Nature Reviews Immunology
Nature· 6 days agoChimeric antigen receptor (CAR) T cell therapies have revolutionized the treatment of B cell and other malignancies, but the limited ...
Cancer cell–immune cell interactions can predict immunotherapy response
Medical Xpress· 3 days agoDr. Chan explained that over the past several decades, researchers have had a growing understanding...
ImmunityBio Drug Gets FDA Nod - Los Angeles Business Journal
Los Angeles Business Journal· 3 days agoApproval clears way for distribution.
Unlocking the immune system: cGAS-STING pathway offers new hope for cancer treatment
Medical Xpress· 2 days agoCancer immunotherapy, which leverages the body's immune system to target tumors, has emerged as a pivotal strategy in oncology. This paradigm shift from conventional treatments offers a more ...
Kill weeds in patio slabs or gravel in hours with simple three-ingredient blend
Daily Express· 6 days agoThe three-ingredient mixture might sound too good to be true, but its effectiveness from a...
ImmunityBio immunotherapy shows positive overall survival in lung cancer trial (NASDAQ:IBRX)
Seeking Alpha· 7 days agoImmunityBio's immunotherapy drug, Anktiva, shows positive results in a trial for non-small cell lung cancer, boosting shares by 17% premarket.
CD70 Antibodies CD70 Targeting Therapies Clinical Trials Market Opportunity Insight
Benzinga· 22 hours agoDelhi, May 01, 2024 (GLOBE NEWSWIRE) -- Global CD70 Targeting Therapies Market Opportunity & Clinical Trials Insight 2024 Report Highlights: CD70 Targeting Therapies In Clinical Trials: > 20 TherapiesCD 70